Total properties:
39
|
|
Patent #:
|
|
Issue Dt:
|
12/02/2014
|
Application #:
|
13436910
|
Filing Dt:
|
03/31/2012
|
Publication #:
|
|
Pub Dt:
|
11/08/2012
| | | | |
Title:
|
SUBSTITUTED N-PHENYLPYRIMIDIN-2-AMINE ANALOGS AS INHIBITORS OF THE AXL KINASE
|
|
|
Patent #:
|
|
Issue Dt:
|
07/19/2016
|
Application #:
|
14435976
|
Filing Dt:
|
04/15/2015
|
Publication #:
|
|
Pub Dt:
|
12/03/2015
| | | | |
Title:
|
PKM2 MODULATORS AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
|
Issue Dt:
|
02/27/2018
|
Application #:
|
15134051
|
Filing Dt:
|
04/20/2016
|
Publication #:
|
|
Pub Dt:
|
10/20/2016
| | | | |
Title:
|
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
|
|
|
Patent #:
|
|
Issue Dt:
|
09/12/2017
|
Application #:
|
15158206
|
Filing Dt:
|
05/18/2016
|
Publication #:
|
|
Pub Dt:
|
11/24/2016
| | | | |
Title:
|
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
|
|
|
Patent #:
|
|
Issue Dt:
|
02/19/2019
|
Application #:
|
15183581
|
Filing Dt:
|
06/15/2016
|
Publication #:
|
|
Pub Dt:
|
01/19/2017
| | | | |
Title:
|
PKM2 MODULATORS AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
|
Issue Dt:
|
04/16/2019
|
Application #:
|
15673213
|
Filing Dt:
|
08/09/2017
|
Publication #:
|
|
Pub Dt:
|
11/23/2017
| | | | |
Title:
|
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
|
|
|
Patent #:
|
|
Issue Dt:
|
02/25/2020
|
Application #:
|
15750151
|
Filing Dt:
|
02/02/2018
|
Publication #:
|
|
Pub Dt:
|
09/13/2018
| | | | |
Title:
|
COMBINATION THERAPIES FOR TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
11/20/2018
|
Application #:
|
15847697
|
Filing Dt:
|
12/19/2017
|
Publication #:
|
|
Pub Dt:
|
06/21/2018
| | | | |
Title:
|
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
|
|
|
Patent #:
|
|
Issue Dt:
|
04/23/2019
|
Application #:
|
16023360
|
Filing Dt:
|
06/29/2018
|
Publication #:
|
|
Pub Dt:
|
10/18/2018
| | | | |
Title:
|
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
|
|
|
Patent #:
|
|
Issue Dt:
|
07/23/2019
|
Application #:
|
16132270
|
Filing Dt:
|
09/14/2018
|
Publication #:
|
|
Pub Dt:
|
01/31/2019
| | | | |
Title:
|
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
|
|
|
Patent #:
|
|
Issue Dt:
|
11/12/2019
|
Application #:
|
16226599
|
Filing Dt:
|
12/19/2018
|
Publication #:
|
|
Pub Dt:
|
04/25/2019
| | | | |
Title:
|
PKM2 MODULATORS AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
|
Issue Dt:
|
09/24/2019
|
Application #:
|
16279623
|
Filing Dt:
|
02/19/2019
|
Publication #:
|
|
Pub Dt:
|
06/13/2019
| | | | |
Title:
|
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
|
|
|
Patent #:
|
|
Issue Dt:
|
02/18/2020
|
Application #:
|
16279958
|
Filing Dt:
|
02/19/2019
|
Publication #:
|
|
Pub Dt:
|
06/13/2019
| | | | |
Title:
|
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
|
|
|
Patent #:
|
|
Issue Dt:
|
05/25/2021
|
Application #:
|
16376452
|
Filing Dt:
|
04/05/2019
|
Title:
|
AXL KINASE INHIBITORS AND USE OF THE SAME
|
|
|
Patent #:
|
|
Issue Dt:
|
04/21/2020
|
Application #:
|
16425826
|
Filing Dt:
|
05/29/2019
|
Publication #:
|
|
Pub Dt:
|
09/19/2019
| | | | |
Title:
|
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
|
|
|
Patent #:
|
|
Issue Dt:
|
03/22/2022
|
Application #:
|
16462094
|
Filing Dt:
|
05/17/2019
|
Publication #:
|
|
Pub Dt:
|
02/13/2020
| | | | |
Title:
|
ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
09/08/2020
|
Application #:
|
16584912
|
Filing Dt:
|
09/26/2019
|
Publication #:
|
|
Pub Dt:
|
04/09/2020
| | | | |
Title:
|
PKM2 MODULATORS AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
|
Issue Dt:
|
11/15/2022
|
Application #:
|
16646853
|
Filing Dt:
|
03/12/2020
|
Publication #:
|
|
Pub Dt:
|
09/03/2020
| | | | |
Title:
|
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 INHIBITOR ALVOCIDIB
|
|
|
Patent #:
|
|
Issue Dt:
|
06/16/2020
|
Application #:
|
16665277
|
Filing Dt:
|
10/28/2019
|
Publication #:
|
|
Pub Dt:
|
02/20/2020
| | | | |
Title:
|
COMBINATION THERAPIES FOR TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
06/15/2021
|
Application #:
|
16703773
|
Filing Dt:
|
12/04/2019
|
Publication #:
|
|
Pub Dt:
|
08/13/2020
| | | | |
Title:
|
CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16730810
|
Filing Dt:
|
12/30/2019
|
Publication #:
|
|
Pub Dt:
|
10/08/2020
| | | | |
Title:
|
METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16755868
|
Filing Dt:
|
04/13/2020
|
Publication #:
|
|
Pub Dt:
|
07/30/2020
| | | | |
Title:
|
PKM2 ACTIVATORS IN COMBINATION WITH REACTIVE OXYGEN SPECIES FOR TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
11/17/2020
|
Application #:
|
16821762
|
Filing Dt:
|
03/17/2020
|
Publication #:
|
|
Pub Dt:
|
07/09/2020
| | | | |
Title:
|
COMBINATION THERAPIES FOR TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
08/01/2023
|
Application #:
|
16826131
|
Filing Dt:
|
03/20/2020
|
Publication #:
|
|
Pub Dt:
|
09/24/2020
| | | | |
Title:
|
COMPOSITIONS COMPRISING PKM2 MODULATORS AND METHODS OF TREATMENT USING THE SAME
|
|
|
Patent #:
|
|
Issue Dt:
|
12/20/2022
|
Application #:
|
16919853
|
Filing Dt:
|
07/02/2020
|
Publication #:
|
|
Pub Dt:
|
01/07/2021
| | | | |
Title:
|
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16930254
|
Filing Dt:
|
07/15/2020
|
Publication #:
|
|
Pub Dt:
|
01/07/2021
| | | | |
Title:
|
PKM2 MODULATORS AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17045411
|
Filing Dt:
|
10/05/2020
|
Publication #:
|
|
Pub Dt:
|
05/20/2021
| | | | |
Title:
|
MATERIALS AND METHODS FOR TREATING CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17061821
|
Filing Dt:
|
10/02/2020
|
Publication #:
|
|
Pub Dt:
|
07/29/2021
| | | | |
Title:
|
COMBINATION THERAPIES FOR TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
08/02/2022
|
Application #:
|
17092521
|
Filing Dt:
|
11/09/2020
|
Publication #:
|
|
Pub Dt:
|
07/08/2021
| | | | |
Title:
|
AXL KINASE INHIBITORS AND USE OF THE SAME
|
|
|
Patent #:
|
|
Issue Dt:
|
12/20/2022
|
Application #:
|
17225836
|
Filing Dt:
|
04/08/2021
|
Publication #:
|
|
Pub Dt:
|
10/28/2021
| | | | |
Title:
|
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17253603
|
Filing Dt:
|
12/17/2020
|
Publication #:
|
|
Pub Dt:
|
09/09/2021
| | | | |
Title:
|
DEUTERATED ALVOCIDIB AND ALVOCIDIB PRODRUGS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17284409
|
Filing Dt:
|
04/09/2021
|
Publication #:
|
|
Pub Dt:
|
12/09/2021
| | | | |
Title:
|
METHODS FOR MONITORING TUMOR LYSIS SYNDROME
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17314896
|
Filing Dt:
|
05/07/2021
|
Publication #:
|
|
Pub Dt:
|
08/26/2021
| | | | |
Title:
|
Alvocidib Prodrugs Having Increased Bioavailability
|
|
|
Patent #:
|
|
Issue Dt:
|
10/24/2023
|
Application #:
|
17435264
|
Filing Dt:
|
08/31/2021
|
Publication #:
|
|
Pub Dt:
|
04/28/2022
| | | | |
Title:
|
Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17439611
|
Filing Dt:
|
09/15/2021
|
Publication #:
|
|
Pub Dt:
|
05/26/2022
| | | | |
Title:
|
PKM2 MODULATORS AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17547799
|
Filing Dt:
|
12/10/2021
|
Publication #:
|
|
Pub Dt:
|
10/27/2022
| | | | |
Title:
|
METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE PROSTATE CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17596805
|
Filing Dt:
|
12/17/2021
|
Publication #:
|
|
Pub Dt:
|
09/29/2022
| | | | |
Title:
|
Treatment of Cancer
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17596807
|
Filing Dt:
|
12/17/2021
|
Publication #:
|
|
Pub Dt:
|
08/18/2022
| | | | |
Title:
|
Treatment of Cancer
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17761993
|
Filing Dt:
|
03/18/2022
|
Publication #:
|
|
Pub Dt:
|
12/01/2022
| | | | |
Title:
|
AXL INHIBITOR FORMULATIONS
|
|